Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Mark - Consider this

Mark - Consider this

posted on Jul 07, 2009 09:03AM

For the sake of argument, let's assume what you posted with respect to inability to collect for past infringement on amended claims is correct. That might have an negative impact on patent owners in general, but how would that effect us, and us alone?

We do not license individual patents, we license a portfolio of several patents. Nor do we distinguish in our licensing between past and future. It's a one time lump sum. So if we continue to license the MMP as a portfolio, how do you see the amended claim 29 impacting us?

Opty

6
Jul 07, 2009 09:16AM
Share
New Message
Please login to post a reply